BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8049107)

  • 1. [Survival following excision of exocrine cancer of the pancreas].
    Peláez Buján MC; Turienzo Santos E; González Martínez J
    Rev Esp Enferm Dig; 1994 May; 85(5):359-62. PubMed ID: 8049107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
    Ridwelski K; Meyer F; Schmidt U; Lippert H
    Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
    Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
    Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Resective surgical treatment of exocrine pancreas neoplasms. Retrospective study of 294 cases and review of the literature].
    Proposito D; Santoro R; Mancini B; Gallina S; Carboni M
    Ann Ital Chir; 1998; 69(1):49-62. PubMed ID: 11995039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinoma of the pancreas: resection outcome at the University Hospital Kuala Lumpur.
    Shahrudin MD
    Int Surg; 1997; 82(3):269-74. PubMed ID: 9372373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pancreatic carcinoma: surgical therapy].
    Baer HU; Wagner M; Sadowski C; Büchler MW
    Ther Umsch; 1996 May; 53(5):394-400. PubMed ID: 8685858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The value of resection in pancreatic cancer: the analysis of an experience of 180 patients in 10 years].
    Ionescu M; Stroescu C; Ciurea S; Dragnea A; Dumitraşcu T; Tănase AM; Popescu I
    Chirurgia (Bucur); 2004; 99(4):211-20. PubMed ID: 15560556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of lymph node metastases in the surgical management of pancreatic head carcinoma.
    Benassai G; Mastrorilli M; Mosella F; Mosella G
    J Exp Clin Cancer Res; 1999 Mar; 18(1):23-8. PubMed ID: 10374672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extent of lymph node retrieval and pancreatic cancer survival: information from a large US population database.
    Schwarz RE; Smith DD
    Ann Surg Oncol; 2006 Sep; 13(9):1189-200. PubMed ID: 16955385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curative resection of pancreatic head carcinoma in recent 30 years: report of 377 cases.
    Ni QX; Zhang QH; Fu DL; Cao GH; Yao QY; Jin C; Yu XJ; Zhang N; Zhang YL
    Hepatobiliary Pancreat Dis Int; 2002 Feb; 1(1):126-8. PubMed ID: 14607640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgery for mucin-producing pancreatic tumor.
    Yasuda H; Takada T; Amano H; Yoshida M
    Hepatogastroenterology; 1998; 45(24):2009-15. PubMed ID: 9951855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer of the exocrine pancreas. A plea for resection.
    Huguier M; Baumel H; Manderscheid JC
    Hepatogastroenterology; 1996; 43(9):721-9. PubMed ID: 8799420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Methods of treatment on different clinical stages in pancreatic cancer].
    Piskorz Ł; Brocki M; Lesiak T; Kutwin L; Jabłonski S; Santorek-Strumiłło EJ; Wcisło S; Kordiak J
    Pol Merkur Lekarski; 2007 May; 22(131):395-8. PubMed ID: 17679378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic carcinoma: reappraisal of surgical experiences in one Japanese university hospital.
    Yamaguchi K; Shimizu S; Yokohata K; Noshiro H; Chijiiwa K; Tanaka M
    Hepatogastroenterology; 1999; 46(30):3257-62. PubMed ID: 10626197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosquamous carcinoma of the pancreas: a single-institution experience comparing resection and palliative care.
    Smoot RL; Zhang L; Sebo TJ; Que FG
    J Am Coll Surg; 2008 Sep; 207(3):368-70. PubMed ID: 18722942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Resection surgery in malignant neoplasms of the exocrine pancreas: our experience, 1987-1994].
    Ghidoni S; Bruni T; Viotto A; Pulica C; Bruni O; Francia L; Tedoli M; Caleffi G; Busani M; Tenchini P
    Chir Ital; 1995; 47(2):50-4. PubMed ID: 8768087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Patients with non-advanced pancreatic cancer benefit from extended lymphadenectomy].
    Popiela T; Kedra B; Sierzega M; Kubisz A
    Zentralbl Chir; 2002 Nov; 127(11):960-4. PubMed ID: 12476369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors.
    Cleary SP; Gryfe R; Guindi M; Greig P; Smith L; Mackenzie R; Strasberg S; Hanna S; Taylor B; Langer B; Gallinger S
    J Am Coll Surg; 2004 May; 198(5):722-31. PubMed ID: 15110805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma.
    Wagner M; Redaelli C; Lietz M; Seiler CA; Friess H; Büchler MW
    Br J Surg; 2004 May; 91(5):586-94. PubMed ID: 15122610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distal pancreatectomy--does it have a role for pancreatic body and tail cancer.
    Kayahara M; Nagakawa T; Ueno K; Ohta T; Kitagawa H; Arakawa H; Yagi H; Tajima H; Miwa K
    Hepatogastroenterology; 1998; 45(21):827-32. PubMed ID: 9684142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.